Edith Uetz Von Allmen

A Unique Signal Sequence of the Chemokine Receptor CCR7 Promotes Package Into COPII Vesicles for Efficient Receptor Trafficking

• Author(s): Edith Uetz-von Allmen, Alexandra V. Rippl, Hesso Farhan, Daniel Legler

• Type: Book
• -
• Published: 2018
• -
• Publisher: Unknown

None

Immune Cell Migration in Health and Disease

• Author(s): Hélène D. Moreau, Jörg Renkawitz, Emmanuel Donnadieu

• Categories: Medical

• Type: Book
• -
• Published: 2022-05-04
• -
• Publisher: Frontiers Media SA

None

CAL-1 as Cellular Model System to Study CCR7-Guided Human Dendritic Cell Migration

• Author(s): Edith Uetz-von Allmen, Guerric P. B. Samson, Vladimir Purvanov, Takahiro Maeda, Daniel Legler

• Type: Book
• -
• Published: 2021
• -
• Publisher: Unknown

None

Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy

• Author(s): Ying Waeckerle-Men, Elke Scandella, Edith Uetz-von Allmen, Burkhard Ludewig, Silke Gillessen, Hans P. Merkle, Bruno Gander, Marcus Groettrup

• Type: Book
• -
• Published: 2004
• -
• Publisher: Unknown

None

Adoptive Immunotherapy

• Author(s): Burkhard Ludewig, Matthias W. Hoffmann

• Categories: Medical

• Type: Book
• -
• Published: 2008-02-02
• -
• Publisher: Springer Science & Business Media

An authoritative collection of optimal techniques for producing and characterizing the immunologically active cells and effector molecules now gaining wide use in the clinical treatment of patients. Taking advantage of the latest technologies, the authors present readily reproducible experimental protocols for the study of dendritic cells, T cells, monoclonal antibodies, and bone marrow transplantation. The emphasis is on preclinicical and clinical applications and on the progress of selected approaches in clinical trials. Additional chapters cover the molecular definition of target antigens, mathematical modeling approaches to immunotherapy, and the utilization of regulatory T cells. The protocols make it possible to study the adoptive transfer of tailored antigen-specific immune cells and to improve the clinical application of adoptive immunotherapy.